The statistical analysis of the collected data aims to reveal the many factors that influence patient involvement in clinical trials. Findings will be disseminated through conferences and scholarly papers to benefit all parties participating in clinical trials. These findings will help to shape the design of future clinical trials for people with tardive dyskinesia, as well as enhance recruiting techniques and retention rates.
Study Type
OBSERVATIONAL
Enrollment
500
Power Life Sciences
San Francisco, California, United States
Rate of patients who decide to enroll in a tardive dyskinesia clinical research.
Time frame: 3 months
Number of tardive dyskinesia study participants who remain in clinical study until completion.
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.